| Medtronic plc | $94.8b | $80.70 | +0.6% | 6.9M | |
| Edwards Lifesciences Corp | $49.8b | $89.72 | +0.1% | 3.1M | |
| Alcon Inc. Ordinary Shares | $32.3b | $68.14 | +0.3% | 1.3M | |
| Biogen Inc. Common Stock | $28.9b | $204.45 | +1.2% | 769.0K | |
| Zimmer Biomet Holdings, Inc. | $15.9b | $90.95 | +0.4% | 1.2M | |
| Glaukos Corporation | $6.1b | $142.45 | +3.5% | 684.4K | |
| Bausch + Lomb Corporation | $5.6b | $15.60 | +2.6% | 300.9K | |
| Denali Therapeutics Inc. Common Stock | $3.3b | $25.42 | -0.4% | 911.0K | |
| Anteris Technologies Global Corp. Common Stock | $0.8b | $10.01 | -5.1% | 1.2M | |
| BioAge Labs, Inc. Common Stock | $0.8b | $22.20 | -1.1% | 878.2K | |
| Bioventus Inc. Class A Common Stock | $0.6b | $9.72 | +2.4% | 527.4K | |
| AC Immune SA | $270.7m | $2.48 | -3.7% | 154.2K | |
| LENZ Therapeutics, Inc. Common Stock | $243.9m | $5.51 | -1.2% | 986.4K | |
| Alector, Inc. Common Stock | $239.8m | $1.91 | +3.1% | 2.8M | |
| Acumen Pharmaceuticals, Inc. Common Stock | $187.8m | $2.21 | -4.3% | 367.8K | |
| Alpha Cognition Inc. Common Stock | $134.8m | $6.48 | -1.2% | 51.4K | |
| Outlook Therapeutics, Inc. Common Stock | $108.5m | $1.63 | -4.5% | 8.7M | |
| Cognition Therapeutics, Inc. Common Stock | $105.6m | $1.10 | +10.3% | 3.9M | |
| Telomir Pharmaceuticals, Inc. Common Stock | $89.4m | $1.25 | +0.4% | 55.0K | |
| Annovis Bio, Inc. | $81.7m | $1.67 | -2.9% | 1.2M | |
| Envoy Medical, Inc. Class A Common Stock | $54.2m | $0.64 | +8.6% | 10.1M | |
| Greenland Mines Ltd. Common Stock | $43.2m | $0.22 | -7.5% | 4.5M | |
| NeuroSense Therapeutics Ltd. Ordinary Shares | $29.7m | $0.75 | -3.9% | 228.3K | |
| CervoMed Inc. Common Stock | $28.8m | $3.25 | +1.8% | 579.0K | |
| Longeveron Inc. Common Stock | $24.4m | $0.77 | -1.8% | 181.1K | |
| OSR Holdings, Inc. Common Stock | $15.3m | $0.33 | -4.9% | 935.7K | |
| HCW Biologics Inc. Common Stock | $14.2m | $1.16 | +0.9% | 219.0K | |
| 20/20 Biolabs, Inc. Common Stock | $9.2m | $0.58 | +4.1% | 371.1K | |
| FibroBiologics, Inc. Common Stock | $6.0m | $0.77 | -5.0% | 78.1K | |
| Alzamend Neuro, Inc. Common Stock | $4.5m | $1.29 | 0.0% | 205.2K |